(Q34825717)

4 August 2017

1 reference

title

The GH-IGF-I axis in children with idiopathic short stature (English)

1 reference

4 August 2017

2

Martin O Savage

1 reference

4 August 2017

Joanne C Blair

1

1 reference

4 August 2017

publication date

1 October 2002

1 reference

Trends in Endocrinology and Metabolism

4 August 2017

published in

1 reference

4 August 2017

volume

13

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

325-330

1 reference

Towards a consensus on the definition of idiopathic short stature

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Evidence for partial growth hormone insensitivity among patients with idiopathic short stature

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Genetic defects of the growth hormone-insulin-like growth factor axis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27-28 March 1998

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Growth hormone neurosecretory dysfunction. A treatable cause of short stature

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Reproducibility of growth hormone testing procedures: a comparison between 24-hour integrated concentration and pharmacological stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Association of pharmacological tests and study of 24-hour growth hormone secretion in the investigation of growth retardation in children: analysis of 257 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

The Advantage of Measuring Stimulated as Compared with Spontaneous Growth Hormone Levels in the Diagnosis of Growth Hormone Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

A distribution method for analysing the baseline of pulsatile endocrine signals as exemplified by 24-hour growth hormone profiles

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Growth hormone secretion in children determined by time series analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

The relationship between height velocity and growth hormone secretion in short prepubertal children

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Study of GH sensitivity in chilean patients with idiopathic short stature

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Peak and trough growth hormone (GH) concentrations influence growth and serum insulin like growth factor-1 (IGF-1) concentrations in short children

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Brief report: short stature caused by a mutant growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Biologically inactive growth hormone caused by an amino acid substitution

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Reduced human growth hormone (hGH) bioactivity without a defect of the GH-1 gene in three patients with rhGH responsive growth failure

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Biological activities of human growth hormone and its derivatives estimated by measuring DNA synthesis in Nb2 node rat lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

The metabolic clearance, distribution, and degradation of dimeric and monomeric growth hormone (GH): implications for the pattern of circulating GH forms

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Heterogeneity of circulating growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Lessons from the genetics of laron syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Review of Turkish patients with growth hormone insensitivity (Laron type)

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Growth hormone receptor and serum binding protein: purification, cloning and expression

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

A dominant-negative mutation of the growth hormone receptor causes familial short stature

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Analysis of the intracellular signalling domain of the human growth hormone receptor in children with idiopathic short stature

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Signal transduction defects in growth hormone insensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Abnormal GH receptor signaling in children with idiopathic short stature

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

The effect of growth hormone treatment on somatomedin levels in growth hormone-deficient children

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Short-term increments of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 predict the growth response to growth hormone (GH) therapy in GH-sensitive children

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Poor Reproducibility of IGF-I and IGF Binding Protein-3 Generation Test in Children with Short Stature and Normal Coding Region of the GH Receptor Gene

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Noonan syndrome revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Serum levels of free insulin-like growth factor (IGF)-I and IGF-binding protein-1 in prepubertal children with idiopathic short stature.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

Insulin-like growth factor binding protein-1: recent findings and new directions.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900631-8

7 January 2021

10.1016/S1043-2760(02)00631-8

Identifiers

DOI

1 reference

4 August 2017

1 reference